Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment - Wikidata - wikimedia - TriplyDB

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

http://www.wikidata.org/entity/Q35030800

about

Hazard assessment of chemical carcinogens: the impact of hormesis.Scaling basic toxicokinetic parameters from rat to man.Assessing and managing risks arising from exposure to endocrine-active chemicals.In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment.Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini-review on fundamental concepts and applications.Tutorial on physiologically based kinetic modeling in molecular nutrition and food research.Uncertainty, Variability, and Sensitivity Analysis in Physiological Pharmacokinetic Models

P2860

Q33861846-F126057D-6A65-4978-B43F-3D635EA65369 Q34635619-F8996195-2D92-426C-A836-C2B7F1063B30 Q37119915-3AE27A95-3CAE-4BEF-91DB-3870A76DE6CE Q37639991-275DDB30-FAB3-4164-AE10-625C5DFAFCBF Q38605894-82F84938-42EC-409A-B326-4198139C5925 Q43778218-AF270B34-D1D1-4425-9481-7D9B4C57B60A Q57491919-01CBBAEE-259F-4386-B67B-4500EE53B8F2

P2860

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

http://www.wikidata.org/entity/Q35030800

description

1994 nî lūn-bûn

@nan

1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@ast

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@en

type

label

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@ast

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@en

prefLabel

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@ast

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@en

P1433

Q35030800-177CB045-06B5-48BC-97AE-2264180BC810

P1476

Q35030800-BDD3FEB6-8D22-4F37-ABE8-71840E249BBE

P2093

Q35030800-10BF748A-A886-4F1F-8F3E-85CFBE5753E2

Q35030800-40996ABD-C94B-462F-B9BE-2DC097477F57

Q35030800-5554F969-A878-4732-935A-B86148021313

Q35030800-E7D3A715-64FE-4C08-9D92-383C1371FB0F

P2860

Q35030800-00EF8FFE-2AA6-47AB-8D96-413CCACFEBE6

Q35030800-0171D8CA-183A-4735-8FFD-9E09B839C303

Q35030800-0444F54C-51DD-4624-9869-E71D7C0FBA53

Q35030800-07017F3B-E7B1-49D6-8A46-3C4048D4BDCB

Q35030800-0D87EC82-8B94-44E9-AD68-6104F01A62C3

Q35030800-154183F2-9C3F-428A-BA24-BB85B6211D7C

Q35030800-157BC56D-030E-4679-B3EB-93B0093B24EF

Q35030800-2475382D-7DEB-4A8E-9C9A-67AF3D77327C

Q35030800-2A08FD82-ED9D-4D1E-A562-A9E767E620CD

Q35030800-2ADA53C5-3209-449D-83E8-315C7F311300

P304

Q35030800-B3B18696-06EB-4BC5-B892-3F5D95A9187A

P31

Q35030800-97EE9015-9773-40F0-81D6-2015A9F3AD99

Q35030800-FE198582-1D74-4635-A0FE-CE1C39A89581

P356

Q35030800-5BBEB127-4DC2-4F4D-B990-9E5F8D583046

P478

Q35030800-83F65105-23F5-40C7-BA20-3E987C76CB03

P577

Q35030800-0AF2D5EA-ED1D-4D6A-B539-F1A6E7FC41EF

P5875

Q35030800-D730105A-B171-4FC7-B0DF-9518F64B0357

P698

Q35030800-B275E96C-56AE-4165-B900-51BF8A47BAC3

P921

Q35030800-5B1A2D57-2257-4229-8493-6577ECC38F45

Q35030800-86A90C6B-E7CA-45B1-B729-B07737313648

Q35030800-EE1206A8-A8CB-4383-BCAE-74C7D1D90709

P932

Q35030800-B6A8BC8C-F5D8-4572-A5EF-C92A44CC3237

P356

P1433

Environmental Health Perspectives

P1476

Applications of physiologic pharmacokinetic modeling in carcinogenic risk assessment

@en

P2093

Andersen ME

http://www.w3.org/2001/XMLSchema#string

Krewski D

http://www.w3.org/2001/XMLSchema#string

Ku LF

http://www.w3.org/2001/XMLSchema#string

Withey JR

http://www.w3.org/2001/XMLSchema#string

P2860

Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 rats.

2,3,7,8-tetrachlorodibenzo-p-dioxin as cocarcinogen causing 3-methylcholanthrene-initiated subcutaneous tumors in mice genetically "nonresponsive" at Ah locus

Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase

2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity

Interspecies extrapolation of toxicity data.

Carbon tetrachloride hepatotoxicity.

Mutation and cancer: a model for human carcinogenesis.

Impaired host resistance to endotoxin and malaria in polychlorinated biphenyl- and hexachlorobenzene-treated mice.

Toxicology of chlorinated dibenzo-p-dioxins

Mechanisms of the biological effects of PCBs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in experimental animals

P304

37-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1289/EHP.94102S1137

http://www.w3.org/2001/XMLSchema#string

P478

102 Suppl 11

http://www.w3.org/2001/XMLSchema#string

P577

1994-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15462229

http://www.w3.org/2001/XMLSchema#string

P698

7737040

http://www.w3.org/2001/XMLSchema#string

P921

pharmaceutical preparation

biomedical investigative technique

P932

1566756

http://www.w3.org/2001/XMLSchema#string